Peter Bolli

Peter Bolli

Auto-generated profile, based on publicly available information

Peter Bolli

McMaster University, Hamilton, Ontario, Canada

Research Focus & Metrics

Academic Career Length

53Years (1974-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 1986 in New England Journal of Medicine
Verified
Journal Article
Closed access
ARAnthony E.G. Raine
Anthony E.G. Raine
PEPaul Erne
Paul Erne
EBErnst Bürgisser
Ernst Bürgisser
FMFranco B. Müller
Franco B. Müller
PBPeter Bolli
Peter Bolli
FBFritz R. Bühler
Fritz R. Bühler
To define the relation between atrial pressures and the release of atrial natriuretic peptide, we measured plasma concentrations of the peptide in 26 patients with cardiac disease — 11 with normal atrial pressures and 15 with elevated atrial pressures (11 of these 15 had elevated pressures in both atria). Mean peptide levels (±SEM) in the peripheral venous blood were increased in the 11 patients with cardiac disease and normal atrial pressures, as compared with 60 healthy controls (48±14 vs. 17±2 pmol per liter). In the patients with elevated atrial pressures, peptide concentrations were increased twofold in peripheral venous, right atrial, pulmonary arterial, and systemic arterial plasma, as compared with the concentrations in the patients with normal atrial pressures.

1 May 2020 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
DRDoreen M. Rabi
Doreen M. Rabi
KMKerry A. McBrien
Kerry A. McBrien
RSRuth Sapir-Pichhadze
Ruth Sapir-Pichhadze
MNMeranda Nakhla
Meranda Nakhla
SASofia B. Ahmed
Sofia B. Ahmed
SDStella S. Daskalopoulou
Stella S. Daskalopoulou

1 May 2018 in Canadian Journal of Cardiology
Verified
Journal Article
Open access
KNKara A. Nerenberg
Kara A. Nerenberg
KZKelly B. Zarnke
Kelly B. Zarnke
Alexander K.C. LeungAlexander K.C. Leung
Alexander K.C. Leung
KDKaberi Dasgupta
Kaberi Dasgupta
SBSonia Butalia
Sonia Butalia
SDStella S. Daskalopoulou
Stella S. Daskalopoulou
Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis, assessment, prevention, and treatment of hypertension in adults and children. This year, the adult and pediatric guidelines are combined in one document. The new 2018 pregnancy-specific hypertension guidelines are published separately. For 2018, 5 new guidelines are introduced, and 1 existing guideline on the blood pressure thresholds and targets in the setting of thrombolysis for acute ischemic stroke is revised. The use of validated wrist devices for the estimation of blood pressure in individuals with large arm circumference is now included. Guidance is provided for the follow-up measurements of blood pressure, with the use of standardized methods and electronic (oscillometric) upper arm devices in individuals with hypertension, and either ambulatory blood pressure monitoring or home blood pressure monitoring in individuals with white coat effect. We specify that all individuals with hypertension should have an assessment of global cardiovascular risk to promote health behaviours that lower blood pressure. Finally, an angiotensin receptor-neprilysin inhibitor combination should be used in place of either an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in individuals with heart failure (with ejection fraction < 40%) who are symptomatic despite appropriate doses of guideline-directed heart failure therapies. The specific evidence and rationale underlying each of these guidelines are discussed.

26 April 1984 in New England Journal of Medicine
Verified
Journal Article
Closed access
PEPaul Erne
Paul Erne
PBPeter Bolli
Peter Bolli
EBErnst Bürgisser
Ernst Bürgisser
FBFritz R. Bühler
Fritz R. Bühler
Intracellular free calcium has been implicated in vascular smooth-muscle contraction and in the pathophysiology of essential hypertension. We studied free-calcium levels in blood platelets, which have many features in common with vascular smooth-muscle cells. With use of an intracellularly trapped fluorescent dye, the free-calcium concentration in platelets was found to be elevated in 9 patients with borderline hypertension and 45 patients with established essential hypertension, who were compared with 38 normotensive subjects. There was a close correlation between the free-calcium level and both systolic and diastolic blood pressure (n = 92; r = 0.883 for systolic pressure and 0.931 for diastolic pressure; P<0.001 for both). Antihypertensive treatment with calcium-entry blockers (n = 15), beta-adrenoceptor blockers (n = 12), or a diuretic (n = 6) resulted in a reduction in free calcium, and this correlated with the fall in blood pressure (P<0.001). The intracellular free-calcium concentration in platelets may be determined by the same humoral or pharmacologic factors that determine the height of blood pressure. (N Engl J Med 1984; 310:1084–8.)

1 May 2016 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
Alexander K.C. LeungAlexander K.C. Leung
Alexander K.C. Leung
KNKara Nerenberg
Kara Nerenberg
SDStella S. Daskalopoulou
Stella S. Daskalopoulou
KMKerry McBrien
Kerry McBrien
KZKelly B. Zarnke
Kelly B. Zarnke
DRDoreen M. Rabi
Doreen M. Rabi

1 May 2015 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
SDStella S. Daskalopoulou
Stella S. Daskalopoulou
DRDoreen M. Rabi
Doreen M. Rabi
KZKelly B. Zarnke
Kelly B. Zarnke
KDKaberi Dasgupta
Kaberi Dasgupta
KNKara Nerenberg
Kara Nerenberg
RPRaj Padwal
Raj Padwal